Intensity Therapeutics
INTS
26 hedge funds and large institutions have $721K invested in Intensity Therapeutics in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 6 closing their positions.
900% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 1
19% more capital invested
Capital invested by funds: $607K → $721K (+$115K)
1.83% more ownership
Funds ownership: 4.2% → 6.04% (+1.8%)
4% less funds holding
Funds holding: 27 → 26 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SL
Sentinus LLC
Oak Brook,
Illinois
|
+$80.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$53.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$36.3K |
| 5 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$25.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$13.8K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$7.54K |
| 3 |
HF
HRT Financial
New York
|
-$7K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$4.61K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.58K |
INTS Hedge Fund Activity: Q3 2025 in Review
26 of the 7,645 institutional investors tracked by Wall St. Rank reported a position in Intensity Therapeutics (INTS) for Q3 2025, worth a combined $721K — up 19% from $607K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of INTS and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 10 added.
The largest buyer was Sentinus LLC, adding an estimated $80.6K. The largest seller was Jane Street, exiting entirely with an estimated $13.8K sold.
- 26 institutional investors held Intensity Therapeutics (INTS) as of Q3 2025, down from 27 in Q2 2025.
- Funds reported $721K of Intensity Therapeutics stock for Q3 2025, up 19% quarter-over-quarter.
- 5 funds opened new Intensity Therapeutics positions in Q3 2025 and 6 closed out, a net change of -1 holder.
- The largest Intensity Therapeutics buyer in Q3 2025 was Sentinus LLC, an estimated $80.6K added.
- The largest Intensity Therapeutics seller in Q3 2025 was Jane Street, an estimated $13.8K sold.
Based on aggregated 13F filings for Q3 2025.